In order to determine whether MMPs and their inhibitors are responsible for the different invasive and metastatic capacities displayed by a panel of five human breast cancer cell lines (Table 1), we analyzed the expression levels of MMPs, TIMPs and RECK by qRT-PCR. The gene discussed is RECK; the disease is breast carcinoma.